Cargando…
Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687300/ https://www.ncbi.nlm.nih.gov/pubmed/23801808 http://dx.doi.org/10.2337/dc13-0038 |
| _version_ | 1782273900973916160 |
|---|---|
| author | Home, Philip D. |
| author_facet | Home, Philip D. |
| author_sort | Home, Philip D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3687300 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36873002014-07-01 Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 Home, Philip D. Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2013-07 2013-06-12 /pmc/articles/PMC3687300/ /pubmed/23801808 http://dx.doi.org/10.2337/dc13-0038 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Online Letters: Comments and Responses Home, Philip D. Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title | Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_full | Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_fullStr | Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_full_unstemmed | Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_short | Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 |
| title_sort | comment on: bergenstal et al. a randomized, controlled study of once-daily ly2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin–treated patients with type 2 diabetes. diabetes care 2012;35:2140–2147 |
| topic | Online Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687300/ https://www.ncbi.nlm.nih.gov/pubmed/23801808 http://dx.doi.org/10.2337/dc13-0038 |
| work_keys_str_mv | AT homephilipd commentonbergenstaletalarandomizedcontrolledstudyofoncedailyly2605541anovellongactingbasalinsulinversusinsulinglargineinbasalinsulintreatedpatientswithtype2diabetesdiabetescare20123521402147 |